CURTISS WRIGHT CORP 8-K Filing

Key Financial Figures

• $416 million — mpany to repurchase up to an additional $416 million of its common stock. The total availabl
• $550 m — k. The total available authorization is $550 million, including $134 million of remain
• $134 million — uthorization is $550 million, including $134 million of remaining availability under the Com
• $60 million — nclude purchases in the total amount of $60 million executed equally over the course of cal
• $100 million — ential purchases in the total amount of $100 million. The Company cannot predict when or if

Filing Documents

• cw-20251120.htm (8-K) — 30KB
• ex991_cwxq425x112125.htm (EX-99.1) — 8KB
• image1a.jpg (GRAPHIC) — 4KB
• imagea.jpg (GRAPHIC) — 15KB
• 0001628280-25-053521.txt ( ) — 179KB
• cw-20251120.xsd (EX-101.SCH) — 2KB
• cw-20251120_lab.xml (EX-101.LAB) — 21KB
• cw-20251120_pre.xml (EX-101.PRE) — 12KB
• cw-20251120_htm.xml (XML) — 3KB

01 Other Events

Item 8.01 Other Events On November 20, 2025, Curtiss-Wright Corporation's (the "Company") Board of Directors authorized the Company to repurchase up to an additional $416 million of its common stock. The total available authorization is $550 million, including $134 million of remaining availability under the Company's previously announced share repurchase authorizations. Share repurchases may be made through a variety of methods, which could include open market purchases, accelerated share repurchase transactions, negotiated block transactions, 10b5-1 plans, other transactions that may be structured through investment banking institutions or privately negotiated, or a combination of the foregoing. The repurchase authorization does not have an expiration date and may be amended, discontinued, or terminated by the Company's Board of Directors at any time without prior notice. The timing, price, and volume of share repurchases will depend on market conditions, relevant securities laws, and corporate, tax, regulatory and other relevant considerations. The Company presently expects to repurchase outstanding shares from time to time to offset the dilutive impact of employee equity-based compensation plans, but the Company also may make discretionary, opportunistic share repurchases. On November 20, 2025, the Company adopted two written trading plans under Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The Company implemented these written trading plans in connection with the above-mentioned and also previously announced share repurchase programs. The first trading plan will include purchases in the total amount of $60 million executed equally over the course of calendar year 2026. This written trading plan will take effect on January 2, 2026, and will cease on December 31, 2026. The second trading plan includes potential purchases in the total amount of $100 million. The Company cannot predict when or if it will purchase any

01. FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS. (a) Not applicable. (b) Not applicable. (c) Not applicable. (d) Exhibits. 99.1 Press Release dated No vember 2 0 , 202 5 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CURTISS-WRIGHT CORPORATION By: /s/ K. Christopher Farkas K. Christopher Farkas Vice President and Chief Financial Officer Date: November 21, 2025